The one that got away: Plagiarism cuts line on fish stock paper

RFBF:Fish Biology newA pair of researchers in India has lost a paper in Reviews in Fish Biology and Fisheries for lifting chunks of text from other sources.

The article, “Advancements in morphometric differentiation: a review on stock identification among fish populations,” appeared in last March from scientists at the National Bureau of Fish Genetic Resources in Lucknow.

According to the retraction notice: Continue reading The one that got away: Plagiarism cuts line on fish stock paper

Paper on over-the-counter drugs goes over the line in borrowing text

crraThe journal Clinical Research and Regulatory Affairs has retracted a 2012 article on over-the-counter drugs by a trio of pharmacy researchers in India who decided to “reproduce content to a high degree of similarity” from other sources.

Here’s how the retraction notice puts it: Continue reading Paper on over-the-counter drugs goes over the line in borrowing text

Papers on potential cancer drugs retracted for image manipulation

ccr 9-13A group of researchers at the Einstein College of Medicine in the Bronx, New York has retracted two papers for image manipulation.

The retraction notices for “PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase” and “The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab” say the same thing: Continue reading Papers on potential cancer drugs retracted for image manipulation

Lancet retracts Jikei Heart Study of valsartan following investigation

logo_lancetThe Lancet has retracted a study of Novartis’ blood pressure drug valsartan (Diovan) that has been subject to an investigation following the retraction of a related study earlier this year.

Continue reading Lancet retracts Jikei Heart Study of valsartan following investigation

Too much skin in the game, as duplications force retraction of psoriasis paper

actadermA group of dermatology researchers from Egypt who passed around a psoriasis paper like a bottle of sunscreen at the beach have been burned (sorry) by a journal that caught them in the act.

Acta Dermatovenerologica Alpina, Pannonica et Adriatica is retracting the 2009 article “Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt” after discovering that they were far from the first publication to print the paper.

Here’s the retraction notice (it’s a pdf): Continue reading Too much skin in the game, as duplications force retraction of psoriasis paper

Math paper retracted because it “contains some ethical problems”

inequalThe Journal of of Inequalities and Applications has retracted a paper for unspecified “ethical problems.”

Here’s the notice for “Strong Limiting Behavior in Binary Search Trees:” Continue reading Math paper retracted because it “contains some ethical problems”

Chemistry papers retracted for “lack of objectivity:” The authors did their own peer review

synthreactSynthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry is retracting three articles for duplication — redundancy the authors, chemical engineers at Islamic Azad University, in Shahreza, Iran, appear to have gotten around by reviewing their own manuscripts. But, if they did say so themselves, those papers were really something!

Here’s the retraction notice for two of the papers, both of which appeared in 2012 and which were cited seven times and once, respectively, according to Thomson Scientific’s Web of Knowledge:
Continue reading Chemistry papers retracted for “lack of objectivity:” The authors did their own peer review

Aussie university asks for retraction, investigates former neurology researcher for fraud

uqThe University of Queensland has decided to get out in front of a serious research misconduct scandal by issuing a press release about the item even before, well, we could get a hold of the story.

The affair involves Bruce Murdoch (all of his links at UQ are defunct), an expert in movement disorders such as Parkinson’s disease. Murdoch isn’t named in the release, but he is the corresponding author of the retracted paper, which is called out in the statement.

According to UQ, Murdoch seems to have published a paper in the European Journal of Neurology on research he never conducted — and on the basis of which he received a $20,000 grant. The paper has been cited six times, according to Thomson Scientific’s Web of Knowledge.

UQ has called for a retraction of the paper, although that does not appear to have happened yet.

Here’s the release, from Peter Høj, president and vice chancellor of the institution, in its entirety: Continue reading Aussie university asks for retraction, investigates former neurology researcher for fraud

Regrettable, but not scientifically dishonest: Klarlund Pedersen responds to Danish committee

Klarlund Pedersen
Klarlund Pedersen

A Danish researcher has responded to a draft report of the Danish Committees on Scientific Dishonesty (DCSD) that found she had acted in a “scientifically dishonest” and “grossly negligent” manner.

Bente Klarlund Pedersen, a University of Copenhagen researcher, has published with Milena Penkowa, four of whose papers have been retracted following investigations. In the press, she argued that while she had made mistakes, she had not committed misconduct.

The 57-page letter from Klarlund Pedersen’s attorney to the DCSD responds in detail to the critique of her work, including twelve papers. This passage from the summary gathers the arguments together: Continue reading Regrettable, but not scientifically dishonest: Klarlund Pedersen responds to Danish committee

Frontiers papers on GMO debate, diabetes retracted for improperly cited text

frontiers plantThe author of a review article on diabetes has been forced to retract the paper after it emerged that he failed to properly credit some of the text — an omission we generally associate with the word plagiarism.

The article, “Colonic flora, probiotics, obesity and diabetes,” was written by Paul Marik, of Eastern Virginia Medical School, and appeared in July 2012 in Frontiers in Endocrinology. It has been cited once, according to Thomson Scientific’s Web of Knowledge.

Here’s the retraction notice:

Continue reading Frontiers papers on GMO debate, diabetes retracted for improperly cited text